142 related articles for article (PubMed ID: 18167131)
1. Genetic polymorphisms of cyclooxygenase-2 and colorectal adenoma risk: the Self Defense Forces Health Study.
Ueda N; Maehara Y; Tajima O; Tabata S; Wakabayashi K; Kono S
Cancer Sci; 2008 Mar; 99(3):576-81. PubMed ID: 18167131
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use and risk of colorectal adenomas: Self-Defense Forces Health Study.
Hirose M; Kono S; Tabata S; Ogawa S; Yamaguchi K; Mineshita M; Hagiwara T; Yin G; Lee KY; Tsuji A; Ikeda N
Cancer Sci; 2005 Aug; 96(8):513-8. PubMed ID: 16108833
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.
Hamachi T; Tajima O; Uezono K; Tabata S; Abe H; Ohnaka K; Kono S
World J Gastroenterol; 2013 Jul; 19(25):4023-30. PubMed ID: 23840148
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study.
Morita M; Tabata S; Tajima O; Yin G; Abe H; Kono S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1800-7. PubMed ID: 18628434
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of cholesterol 7alpha-hydroxylase (CYP7A1) and colorectal adenomas: Self Defense Forces Health Study.
Tabata S; Yin G; Ogawa S; Yamaguchi K; Mineshita M; Kono S
Cancer Sci; 2006 May; 97(5):406-10. PubMed ID: 16630139
[TBL] [Abstract][Full Text] [Related]
6. COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk.
Hoff JH; te Morsche RH; Roelofs HM; van der Logt EM; Nagengast FM; Peters WH
World J Gastroenterol; 2009 Sep; 15(36):4561-5. PubMed ID: 19777615
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 genetic polymorphism and stroke subtypes in Chinese.
Chen GZ; Shan XY; Cheng GP; Tao HM
J Mol Neurosci; 2013 Oct; 51(2):467-73. PubMed ID: 23907768
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase 2 1195G > A polymorphism is associated with chronic obstructive pulmonary disease in Japanese and Chinese patients.
Chen LJ; Xu W; Taooka Y; Ohe M; Takahashi H; Sutani A; Kuraki T; Isobe T
Chin Med J (Engl); 2013 Jun; 126(12):2215-21. PubMed ID: 23786928
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase 2 genetic polymorphism may increase the risk of developing leukoaraiosis in Chinese.
Shan XY; Chen GZ; Cheng GP; Tao HM
J Mol Neurosci; 2013 Oct; 51(2):461-6. PubMed ID: 23852948
[TBL] [Abstract][Full Text] [Related]
10. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
[TBL] [Abstract][Full Text] [Related]
11. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
12. COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention.
Pereira C; Pimentel-Nunes P; Brandão C; Moreira-Dias L; Medeiros R; Dinis-Ribeiro M
Eur J Gastroenterol Hepatol; 2010 May; 22(5):607-13. PubMed ID: 20075740
[TBL] [Abstract][Full Text] [Related]
13. Lack of influence of the ADH1B Arg47His genetic polymorphism on risk of colorectal adenoma in middle-aged Japanese men.
Yin G; Hamajima N; Morita M; Tajima O; Tabata S; Kono S
Asian Pac J Cancer Prev; 2011; 12(1):297-302. PubMed ID: 21517275
[TBL] [Abstract][Full Text] [Related]
14. Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.
Kwagyan J; Apprey V; Ashktorab H
Clin Transl Sci; 2012 Feb; 5(1):60-4. PubMed ID: 22376259
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein and colorectal adenomas: Self Defense Forces Health Study.
Otake T; Uezono K; Takahashi R; Fukumoto J; Tabata S; Abe H; Tajima O; Mizoue T; Ohnaka K; Kono S
Cancer Sci; 2009 Apr; 100(4):709-14. PubMed ID: 19469014
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ülger Y
Mol Cell Biochem; 2011 Jan; 347(1-2):201-8. PubMed ID: 21042835
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between single nucleotide polymorphisms in the promoter of COX-2 gene and hereditariness to NAFLD].
Cao MB; Yang YX; Dong L
Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):773-7. PubMed ID: 21059296
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 gene and lung carcinoma risk.
Coskunpinar E; Eraltan IY; Turna A; Agachan B
Med Oncol; 2011 Dec; 28(4):1436-40. PubMed ID: 20645029
[TBL] [Abstract][Full Text] [Related]
20. Roles of Cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis.
Luo MX; Long BB; Li F; Zhang C; Pan MT; Huang YQ; Chen B
Gene; 2019 Feb; 685():125-135. PubMed ID: 30391440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
